Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

Toxoplasma infection leads to a decrease in the concentration of EVs. by Emily Z. Tabaie (16630841)

Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…Representative images of the frontal cortex (A–D), cerebral nuclei (F–I), brain stem (K–N), thalamus (P–S), and hippocampus (U–X) 15 days post-infection are shown. …”

Content analysis of groups with decreased confidence. by Yasutaka Yanagita (11105508)

“…<p>Content analysis of groups with decreased confidence.</p>…”

JHMV N1347A has decreased replication in the olfactory bulbs of mice. by Catherine M. Kerr (21492574)

Subjects:

An increase in MOI decreases neuronal dendrite numbers. by Emily Z. Tabaie (16630841)

ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”

Severe decrease in ridge numbers on the surface of iRBCs. by Atefeh Fathi (7370876)

Voxel-based whole-hemisphere analysis shows regional and dose-dependent decrease of microglia. by Francesca Catto (21253435)

“…For the late high dose treatment, the decrease in Aβ plaque count was also colocalized with decreased microglia.…”

SBP3 KD decreases cytoadhesion of iRBCs to bovine brain endothelial cells (BBECs). by Atefeh Fathi (7370876)

Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0. by Danielle Sambo (6077924)

SBP3 KD decreases the surface localization of VESA-1. by Atefeh Fathi (7370876)

Naringenin decreases total cell viability. by Lauren A. Eanes (20995499)

HFD decreases intermediate-term memory. by Tong Yue (6033305)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

“…Each map represents a 3-dimensional view of statistically affected voxels (p < 0.05), where the red scale indicates a decrease in plaque count, and the cyan scale represents an increase. …”

Mod loss is associated with a reduction of central brain NBs. by Amalia S. Parra (4173004)

Subjects:

RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. by Will Campodonico (20485651)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…(D) Long-term treatment with a high dose of netoglitazone displays a decrease in plaque size, particularly observed in the orbital cortex, olfactory area, hippocampus, thalamus, hypothalamus, midbrain, and hindbrain regions.…”

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. by Katherine Schubert (5452712)